Chlorimipramine as the major treatment of depressive states (103 cases treated with intravenous perfusion)
Maillet-Jurquet, A.; Rance, A.M.; Tollinchi, G.; Rance, A.; Roger, J.
L'Encephale 59(2): 180-188
1970
ISSN/ISBN: 0013-7006 PMID: 5458712 Document Number: 30721
Document emailed within 1 workday
Related Documents
Escobar, J.I.; Teeter, R.R.; Tuason, V.B.; Schiele, B.C. 1976: Intravenous chlorimipramine and depressive subtypes Diseases of the Nervous System 37(6): 325-328Brasseur, R. 1972: Value of Déanxit in the ambulatory treatment of depressive states. Clinical study of 205 cases Schweizerische Rundschau für Medizin Praxis 61(37): 1153-1156
de Campos, R.M. 1970: Chlorimipramine in the depressive manifestations of severe neuroses Hospital (Rio de Janeiro) 77(3): 913-918
Bercegeay, R.; Le Roux, J.L. 1975: Value of combination of sulpiride and clomiprmaine in certain depressive states (apropos of 2 cases Semaine des Hopitaux. Therapeutique 51(3): 209-210
Leckman, J.F.; Gillin, J.C.; Sitaram, N.; Duncan, W.; Wyatt, R.J. 1980: Intravenous chlorimipramine affects REM cycle in patients with excessive daytime sleepiness and control subjects Communications in Psychopharmacology 4(1): 35-40
Thase, M.E.; Blomgren, S.L.; Birkett, M.A.; Apter, J.T.; Tepner, R.G. 1997: Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline Journal of Clinical Psychiatry 58(1): 16-21
Pchelina, A.L. 1980: Clinical picture of protracted depressive and depressive-paranoid states Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 80(9): 1371-1376
Tremblay, M.; Bernheim, J.; Berthoux, F.; Zech, P.; Traeger, J. 1975: Acute renal insufficiency after intravenous urography by perfusion in cases of diabetic nephropathy L'Union Medicale du Canada 104(8): 1242-1246
Laux, G.; Beckmann, H.; Classen, W.; Becker, T. 1989: Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder Journal of Neural Transmission. Supplementum 28: 45-52
Borrelli, B.; Niaura, R.; Keuthen, N.J.; Goldstein, M.G.; DePue, J.D.; Murphy, C.; Abrams, D.B. 1996: Development of major depressive disorder during smoking-cessation treatment Journal of Clinical Psychiatry 57(11): 534-538
Bailey, R.K.; Mallinckrodt, C.H.; Wohlreich, M.M.; Watkin, J.G.; Plewes, J.M. 2006: Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy Journal of the National Medical Association 98(3): 437-447
Akkaya, C. 2006: Difficulties in the diagnosis and treatment of major depressive disorder with comorbid anxiety symptoms Turk Psikiyatri Dergisi 17(2): 139-146
Rasgon, N.L.; Altshuler, L.L.; Fairbanks, L.A.; Dunkin, J.J.; Davtyan, C.; Elman, S.; Rapkin, A.J. 2002: Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women Journal of Clinical Psychiatry 63(Suppl): 45-48
Snedecor, S.J.; Botteman, M.F.; Schaefer, K.; Sarocco, P.; Barry, N.; Pickard, A.S. 2010: Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder Journal of Mental Health Policy and Economics 13(1): 27-35
Bilikiewicz, A.; Nowicki, Z. 1970: Treatment of schizophrenized depressive states based on our personal clinical studies Psychiatria Polska 4(4): 443-448
Balogh, S.; Fitzpatrick, D.F.; Hendricks, S.E.; Paige, S.R. 1993: Increases in heart rate variability with successful treatment in patients with major depressive disorder Psychopharmacology Bulletin 29(2): 201-206
Fillastre, J.P.; Maitrot, J.; Canonne, M.A.; Gray, H.; Jeanne, C.; Bastit, P.; Bourgeois, T. 1974: Renal function and treatment by intravenous perfusion of Mithramycin Journal d'Urologie et de Nephrologie 80(9): 749-753
Kongsakon, R.; Bunchapattanasakda, C. 2008: The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation Journal of the Medical Association of Thailand 91(7): 1117-1128
Schmidt, M.E.; Fava, M.; Robinson, J.M.; Judge, R. 2000: The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder Journal of Clinical Psychiatry 61(11): 851-857
Leelahanaj, T. 2012: Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial Journal of the Medical Association of Thailand 95(Suppl 5): S29-S37